<SEC-DOCUMENT>0001193125-17-094026-index.html : 20170324 <SEC-HEADER>0001193125-17-094026.hdr.sgml : 20170324 <ACCEPTANCE-DATETIME>20170323190903 ACCESSION NUMBER: 0001193125-17-094026 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20170322 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20170324 DATE AS OF CHANGE: 20170323 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 17710877 BUSINESS ADDRESS: STREET 1: 10182 TELESIS COURT, 6TH FLOOR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 10182 TELESIS COURT, 6TH FLOOR CITY: SAN DIEGO STATE: CA ZIP: 92121 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>d345490d8k.htm <DESCRIPTION>FORM 8-K <TEXT> Document 1 - file: d345490d8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1.1 <SEQUENCE>2 <FILENAME>d345490dex11.htm <DESCRIPTION>EX-1.1 <TEXT> Document 2 - file: d345490dex11.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>3 <FILENAME>d345490dex51.htm <DESCRIPTION>EX-5.1 <TEXT> Document 3 - file: d345490dex51.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>g345490g84d65.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: g345490g84d65.jpg
</DOCUMENT> </SEC-DOCUMENT>